is the new normal

Deloitte Center for Health Solutions reports that consumers are now more willing to adopt tools and share data; new digital tools can play an important role in the future of care.

Members that benefit

Sozos reviews medical and pharmacy claims data and through our algorithms, identify members at highest risk for medication related health problems. Through pharmacogenetic testing of high-risk members, we can reduce acute care risk and costs associated with hospitalizations, typically linked to medication related health problems.

The only solution that predicts down to the Ingredient level

Sozos uses patent-pending technology, called TruTYPE and personal diagnostics to help healthcare professionals quickly estimate if a given enzyme is functioning differently than reported.

The customer experience

Tests can be performed during annual wellness visits for easy administration for high-risk members. Members will have access to these results with a user-friendly mobile app.